PatientsVille.com Logo

PatientsVille

Mucodyne Side Effects

Common Mucodyne Side Effects


The most commonly reported Mucodyne side effects (click to view or check a box to report):

Pneumonia (6)
Diarrhoea (4)
Blood Glucose Increased (3)
Blood Lactate Dehydrogenase Decreased (3)
Blood Pressure Decreased (3)
Cheilitis (3)
Dermatitis Exfoliative (3)
Blood Creatinine Decreased (3)
Pallor (3)
Fall (3)
Neutrophil Count Increased (3)
Respiratory Failure (3)
Lymphocyte Count Decreased (3)
Feeling Hot (3)
Pancytopenia (2)
Petit Mal Epilepsy (2)
Oedema Peripheral (2)
Nasopharyngitis (2)
Lung Neoplasm Malignant (2)
Nephrotic Syndrome (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Mucodyne Side Effects Reported to FDA

The following Mucodyne reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Mucodyne on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Cardio-respiratory Arrest, Pneumonia, Condition Aggravated
This is a report of a 89-year-old male patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Mucodyne (carbocisteine) (dosage: NA, start time: Apr 23, 2012), combined with:
  • Maglax (magnessium Oxide)
  • Casodex
  • Nu-lotan (loartan Potassium)
  • Sol-melcort (methylprednisolone Sodium Succinate)
  • Rozerem (8 Mg (8 Mg, 1 In 1 D), Per Oral)
  • Flivas Od (naftopidil)
  • Lendem D (brotizolam)
  • Sulbacillin (ampicillin Sodium, Sulbactam Sodium)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Cardio-respiratory Arrest
  • Pneumonia
  • Condition Aggravated
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mucodyne (carbocisteine) treatment in male patients, resulting in cardio-respiratory arrest side effect.

Pancytopenia
This report suggests a potential Mucodyne Pancytopenia side effect(s) that can have serious consequences. A 37-year-old female patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Mucodyne (dosage: Daily Dose 1500 Mg) starting Apr 28, 2012. Soon after starting Mucodyne the patient began experiencing various side effects, including:
  • Pancytopenia
Drugs used concurrently:
  • Adona (Daily Dose 90 Mg)
  • Keppra
  • Meilax (Daily Dose 1 Mg)
  • Panvitan (Daily Dose 1 Gm)
  • Transamine Cap (Daily Dose 750 Mg)
  • Clobazam (Daily Dose 20 Mg)
  • Lansoprazole (Daily Dose 15 Mg)
  • Magmitt (Daily Dose 990 Mg)
Although Mucodyne demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as pancytopenia, may still occur.

Pulmonary Congestion, Nasopharyngitis, Cough
This Pulmonary Congestion, Nasopharyngitis, Cough problem was reported by a pharmacist from JAPAN. A 25-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Mucodyne (dosage: NA). The following drugs were being taken at the same time:
  • Aldactone (50 Mg, Daily)
  • Codeine Phosphate
  • Garenoxacin Mesilate
  • Flomox
When commencing Mucodyne, the patient experienced the following unwanted symptoms/side effects:
  • Pulmonary Congestion
  • Nasopharyngitis
  • Cough
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as pulmonary congestion, may become evident only after a product is in use by the general population.

Pneumonia Bacterial, Lung Disorder, Interstitial Lung Disease
This is a report of a female patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: supportive care,colitis ulcerative,gastrooesophageal reflux disease and was treated with Mucodyne (dosage: 1500 Mg And 500 Mg Once A Day) starting Jan 30, 2012. Concurrently used drugs:
  • Remicade (First Dose)
  • Rabeprazole Sodium
  • Remicade (Fourth Dose)
  • Asacol
  • Theolong (2 Tab And 1 Tab, Once A Day)
Soon after that, the consumer experienced the following side effects:
  • Pneumonia Bacterial
  • Lung Disorder
  • Interstitial Lung Disease
The patient was hospitalized. This opens a possibility that Mucodyne treatment could cause the above reactions, including pneumonia bacterial, and some female subjects may be more susceptible.


Pyrexia, Malignant Pleural Effusion, Altered State Of Consciousness, Condition Aggravated, Electrocardiogram St-t Segment Abnormal, Bundle Branch Block Left, Respiratory Failure, Mouth Breathing, Lung Neoplasm Malignant
A 84-year-old male patient (weight: NA) from JAPAN with the following symptoms/conditions: NA started Mucodyne (carbocisteine) treatment (dosage: NA) on Feb 25, 2005. Soon after starting Mucodyne (carbocisteine) treatment, the subject experienced various side effects, including:
  • Pyrexia
  • Malignant Pleural Effusion
  • Altered State Of Consciousness
  • Condition Aggravated
  • Electrocardiogram St-t Segment Abnormal
  • Bundle Branch Block Left
  • Respiratory Failure
  • Mouth Breathing
  • Lung Neoplasm Malignant
Concurrently used drugs:
  • Unasyn
  • Broact (cefpirome Sulfate)
  • Bisolvon (bromhexine Hydrochloride)
  • Pletal (100 Mg, Bid, Other)
  • Valproate Sodium
This finding indicates that some male patients could be more vulnerable to Mucodyne (carbocisteine).

Hypertension
A 73-year-old male patient from JAPAN (weight: NA) experienced symptoms, such as: NA and was treated with Mucodyne (carbocisteine)(dosage: NA). The treatment was initiated on May 09, 2012. After that a consumer reported the following side effect(s):
  • Hypertension
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Mucodyne (carbocisteine) efficacy:
  • Mirabegron (50 Mg)
  • Tamsulosin Hcl (0.2 Mg)
  • Zolpidem (10 Mg)
  • Eviprostat (chimaphila Umbellata, Equisetum Arvense, Manganese Chlorid
  • Rabeprazole Sodium
  • Gasmotin (mosapride Citrate)
  • Dogmatyl (50 Mg)
  • Cerocral (ifenprodil Tartrate)


Hypogeusia
In this report, Mucodyne was administered for the following condition: sinusitis,oropharyngeal discomfort.A male consumer from JAPAN (weight: NA) started Mucodyne treatment (dosage: NA) on Dec 20, 2011.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Hypogeusia
A possible interaction with other drugs could have contributed to this reaction:
  • Hangekobokuto
  • Clarithromycin
  • Onon
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Mucodyne treatment could be related to the listed above side effect(s).

Ocular Hyperaemia, Oral Pain, Erythema
This is a report of the following Mucodyne side effect(s):
  • Ocular Hyperaemia
  • Oral Pain
  • Erythema
A 65-year-old male patient from JAPAN (weight: NA) presented with the following condition: NA and received a treatment with Mucodyne (dosage: NA) starting: Nov 15, 2011.The following concurrently used drugs could have generated interactions:
  • Amoxicillin
  • Clarithromycin
  • Amlodipine Besylate
  • Allegra
  • Hmg Coa Reductase Inhibitors
  • Olmesartan Medoxomil
  • Empynase
The patient was hospitalized.This report suggests that a Mucodyne treatment could be associated with the listed above side effect(s).

Hypoaesthesia, Application Site Pain
This Mucodyne report was submitted by a 52-year-old male consumer from UNITED KINGDOM (weight: NA). The patient was diagnosed with: NA and Mucodyne was administered (dosage: NA) starting: Apr 16, 2012. The consumer developed a set of symptoms:
  • Hypoaesthesia
  • Application Site Pain
Other drugs used simultaneously:
  • Dipyridamol
  • Fluticasone Propionate/salmeterol
  • Spiriva
  • Albuterol
  • Nicotine
Those unexpected symptoms could be linked to a Mucodyne treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Liver Function Test Abnormal, Palmar-plantar Erythrodysaesthesia Syndrome, Amylase Increased, Hypertension, Mouth Haemorrhage, Hepatic Function Abnormal
This is a report of a possible correlation between Mucodyne use and the following symptoms/side effect(s):
  • Liver Function Test Abnormal
  • Palmar-plantar Erythrodysaesthesia Syndrome
  • Amylase Increased
  • Hypertension
  • Mouth Haemorrhage
  • Hepatic Function Abnormal
which could contribute to an assessment of Mucodyne risk profile.A 78-year-old male consumer from JAPAN (weight: NA) was suffering from NA and was treated with Mucodyne (dosage: 2 Df (daily Dose), , Oral) starting Nov 02, 2009.Other concurrent medications:
  • Nexavar (400 Mg (daily Dose))
The patient was hospitalized.

Bone Marrow Failure
A 63-year-old male patient from JAPAN (weight: NA) presented with the following symptoms: NA and after a treatment with Mucodyne (dosage: Unk) experienced the following side effect(s):
  • Bone Marrow Failure
The treatment was started on Jul 20, 2010. Mucodyne was used in combination with the following drugs:
  • Transamine Cap (Unk)
  • Morphine Hydrochloride (Unk)
  • Hochuuekkitou (Unk)
  • Alimta (500 Mg/m2, Unk)
  • Selbex (Unk)
  • Mucosolvan (Unk)
  • Aloxi (Unk)
  • Micardis (Unk)
This report could alert potential Mucodyne consumers.

Torticollis
In this report, a 11-year-old male patient from JAPAN (weight: NA) was affected by a possible Mucodyne side effect.The patient was diagnosed with NA. After a treatment with Mucodyne (dosage: NA, start date: NS), the patient experienced the following side effect(s):
  • Torticollis
The following simultaneously used drugs could have led to this reaction:
  • Ambroxol Hydrochloride
  • Spiropent
  • Azeptin
  • Risperdal
  • Singulair
  • Meptin
  • Pranlukast
The findings here stress that side effects should be taken into consideration when evaluating a Mucodyne treatment.

Myositis
This is a report of a 90-year-old female patient from JAPAN (weight: NA), who used Mucodyne (dosage: NA) for a treatment of NA. After starting a treatment on Feb 07, 2012, the patient experienced the following side effect(s):
  • Myositis
The following drugs could possibly have interacted with the Mucodyne treatment
  • Zolpidem
  • Etizolam
  • Inderal
  • Celebrex (100 Mg, 2x/day)
  • Alfarol
  • Triteren
  • Pravastatin
The patient was hospitalized.Taken together, these observations suggest that a Mucodyne treatment could be related to side effect(s), such as Myositis.

Palpitations, Overdose
This palpitations side effect was reported by a pharmacist from JAPAN. A 25-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Mucodyne (dosage: NA), which was started on Mar 22, 2012. Concurrently used drugs:
  • Fluticasone Propionate/salmeterol (14iuax Per Day)
  • Zithromax
When starting to take Mucodyne the consumer reported the following symptoms:
  • Palpitations
  • Overdose
The patient was hospitalized. These side effects may potentially be related to Mucodyne.

Bile Duct Cancer
This is a Mucodyne side effect report of a 76-year-old male patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: NA, who was treated with Mucodyne (dosage:Dosage Is Uncertain During A Day., start time: Jul 14, 2008), combined with:
  • Mucosta (Dosage Is Uncertain During A Day.)
  • Mucosolvan (Dosage Is Uncertain During A Day.)
  • Dasen (Dosage Is Uncertain During A Day.)
  • Loxonin (Dosage Is Uncertain During A Day.)
  • Zetia (Dose Not Changed)
  • Dogmatyl (Dosage Is Uncertain During A Day.)
  • Alprazolam (Dosage Is Uncertain During A Day.)
  • Protecadin (The Divided Dose Frequency Is Uncertain.)
, and developed a serious reaction and a bile duct cancer side effect. The patient presented with:
  • Bile Duct Cancer
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Mucodyne treatment in male patients suffering from NA, resulting in bile duct cancer.

Agitation
This report suggests a potential Mucodyne agitation side effect(s) that can have serious consequences. A male patient from JAPAN (weight:NA) was diagnosed with the following health condition(s): nasopharyngitis and used Mucodyne (dosage: NA) starting Feb 16, 2012. Soon after starting Mucodyne the patient began experiencing various side effects, including:
  • Agitation
Drugs used concurrently:
  • Clarithromycin
  • Zesulan
  • Relenza (10mg Per Day)
Although Mucodyne demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as agitation, may still occur.

Aggression
This aggression problem was reported by a physician from JAPAN. A 10-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Feb 29, 2012 a consumer started treatment with Mucodyne (dosage: NA). The following drugs/medications were being taken at the same time:
  • Tulobuterol
  • Relenza (20mg Per Day)
When commencing Mucodyne, the patient experienced the following unwanted symptoms /side effects:
  • Aggression
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as aggression, may become evident only after a product is in use by the general population.

Liver Disorder, Hepatitis Fulminant
This is a Mucodyne side effect report of a female patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: rhinitis and was treated with Mucodyne (dosage: NA) starting Aug 06, 2010. Concurrently used drugs:
  • Solon
  • Protecadin
  • Zesulan
  • Clarithromycin
  • Pronase
Soon after that, the consumer experienced the following of symptoms:
  • Liver Disorder
  • Hepatitis Fulminant
The patient was hospitalized. This opens a possibility that Mucodyne could cause liver disorder and that some female patients may be more susceptible.

Hearing Impaired
A 13-year-old female patient (weight: NA) from JAPAN with the following symptoms: NA started Mucodyne treatment (dosage: 750 Mg, 1x/day) on Jan 14, 2012. Soon after starting Mucodyne treatment, the consumer experienced several side effects, including:
  • Hearing Impaired
. Concurrently used drugs:
  • Leftose (30 Mg, 1x/day)
  • Acetaminophen (200 Mg, As Needed)
  • Flaveric (1.2 Mg, 1x/day)
This finding indicates that some patients can be more vulnerable to developing Mucodyne side effects, such as hearing impaired.

Small Intestinal Perforation, Diarrhoea, Diverticulum Intestinal, Malignant Tumour Excision
This small intestinal perforation side effect was reported by a consumer or non-health professional from JAPAN. A 57-year-old male patient (weight:NA) experienced the following symptoms/conditions: productive cough,constipation prophylaxis,hyperchlorhydria.The patient was prescribed Mucodyne (dosage: NA), which was started on Oct 01, 2011. Concurrently used drugs:
  • Pursennid /00142207/
  • Rabeprazole Sodium
  • Fosrenol
  • Calcium Carbonate
  • Allegra
  • Fosrenol
  • Harnal D
  • Micardis (120 Mg, 1x/week)
.When starting to take Mucodyne the consumer reported symptoms, such as:
  • Small Intestinal Perforation
  • Diarrhoea
  • Diverticulum Intestinal
  • Malignant Tumour Excision
These side effects may potentially be related to Mucodyne. The patient was hospitalized.

Blood Pressure Decreased, Vomiting, Loss Of Consciousness, Facial Pain, Decreased Appetite, Dizziness, Nausea, Renal Impairment
This is a report of a 69-year-old female patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: sinusitis,hypertension,facial pain, who was treated with Mucodyne (dosage: 1000 Mg, 1x/day, start time: Dec 22, 2011), combined with:
  • Norvasc (5 Mg, 1x/day)
  • Lyrica (50 Mg, 2x/day)
  • Lyrica (25 Mg/day)
  • Cleanal (400 Mg, 1x/day)
  • Neurotropin (8 Iu, 2x/day)
  • Methycobal (500 Ug, 3x/day)
  • Doxazosin Mesilate (1 Mg, 1x/day)
  • Famotidine (20 Mg, 1x/day)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Blood Pressure Decreased
  • Vomiting
  • Loss Of Consciousness
  • Facial Pain
  • Decreased Appetite
  • Dizziness
  • Nausea
  • Renal Impairment
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Mucodyne treatment in female patients, resulting in blood pressure decreased side effect. The patient was hospitalized.

Petit Mal Epilepsy
This report suggests a potential Mucodyne Petit Mal Epilepsy side effect(s) that can have serious consequences. A 4-year-old male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Mucodyne (dosage: NA) starting Nov 25, 2010. Soon after starting Mucodyne the patient began experiencing various side effects, including:
  • Petit Mal Epilepsy
Drugs used concurrently:
  • Intal
  • Pulmicort-100
  • Meptin
  • Zaditen
  • Mucosolvan
  • Singulair
  • Claritin
Although Mucodyne demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as petit mal epilepsy, may still occur.

Interstitial Lung Disease
This Interstitial Lung Disease problem was reported by a physician from JAPAN. A 70-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Apr 01, 2011 this consumer started treatment with Mucodyne (dosage: NA). The following drugs were being taken at the same time:
  • Januvia
  • Spiriva
  • Cisplatin
  • Gramicidin S Hydrochloride And Neomycin Sulfate
  • Etoposide
  • Lansoprazole
  • Fluvastatin
  • Magnesium Oxide
When commencing Mucodyne, the patient experienced the following unwanted symptoms/side effects:
  • Interstitial Lung Disease
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as interstitial lung disease, may become evident only after a product is in use by the general population.

Lung Neoplasm Malignant, Bronchitis
This is a report of a 65-year-old male patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: NA and was treated with Mucodyne (dosage: Total Daily Dose : 1500 Mg) starting Sep 29, 2011. Concurrently used drugs:
  • Allopurinol (Total Daily Dose : 100 Mg)
  • Wystal (Total Daily Dose : 1 G)
  • Amsulmylan (Total Daily Dose : 3 Gm)
  • Norvasc (Total Daily Dose : 5 Mg)
  • Keppra
Soon after that, the consumer experienced the following side effects:
  • Lung Neoplasm Malignant
  • Bronchitis
This opens a possibility that Mucodyne treatment could cause the above reactions, including lung neoplasm malignant, and some male subjects may be more susceptible.

Petit Mal Epilepsy
A 4-year-old male patient (weight: NA) from JAPAN with the following symptoms/conditions: NA started Mucodyne treatment (dosage: NA) on Aug 11, 2010. Soon after starting Mucodyne treatment, the subject experienced various side effects, including:
  • Petit Mal Epilepsy
Concurrently used drugs:
  • Zaditen
  • Meptin
  • Mucosolvan
  • Pulmicort-100
  • Claritin
  • Singulair
  • Intal
This finding indicates that some male patients could be more vulnerable to Mucodyne.

1 of 3 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Mucodyne Side Effects

    Did You Have a Mucodyne Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Mucodyne for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective